--2025/Q1-- / 1.633M--
--2024/Q4-- / 1.480M--
--2024/Q32.336M / 4.580M--
--2024/Q22.045M / 3.013M--
--2024/Q13.543M / 2.570M--
Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
RNA Avidity Biosciences
- 30.700
- -2.040-6.23%
Close Dec 18 16:00 ET
- 31.740
- +1.040+3.39%
Pre 04:32 ET
3.66BMarket Cap-10.66P/E (TTM)
34.160High30.560Low1.86MVolume32.750Open32.740Pre Close59.49MTurnover2.01%Turnover RatioLossP/E (Static)119.31MShares56.00052wk High2.44P/B2.84BFloat Cap8.86052wk Low--Dividend TTM92.43MShs Float56.000Historical High--Div YieldTTM11.00%Amplitude4.825Historical Low31.960Avg Price1Lot Size
Avidity Biosciences Key Stats
Avidity Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Avidity Biosciences Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data